CelSci (CVM)
(Delayed Data from AMEX)
$1.22 USD
+0.02 (1.67%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $1.21 -0.01 (-0.82%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Cel-Sci Corporation [CVM]
Reports for Purchase
Showing records 21 - 29 ( 29 total )
Company: Cel-Sci Corporation
Industry: Medical - Biomedical and Genetics
Company: Cel-Sci Corporation
Industry: Medical - Biomedical and Genetics
Company: Cel-Sci Corporation
Industry: Medical - Biomedical and Genetics
Arbitration date with former CRO set for May 2015.
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Company: Cel-Sci Corporation
Industry: Medical - Biomedical and Genetics
Research Update: Arbitration date with former CRO set for May 2015
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Company: Cel-Sci Corporation
Industry: Medical - Biomedical and Genetics
Initiation of Coverage: CVM: Unique cancer therapy looking to unlock potential
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Company: Cel-Sci Corporation
Industry: Medical - Biomedical and Genetics
Dropping coverage due to termination of research services.
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J
Company: Cel-Sci Corporation
Industry: Medical - Biomedical and Genetics
Maintaining Speculative Buy rating and $0.70 (12-month) price target.
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J
Company: Cel-Sci Corporation
Industry: Medical - Biomedical and Genetics
Maintaining Speculative Buy rating and $0.70 (12-month) price target
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J
Company: Cel-Sci Corporation
Industry: Medical - Biomedical and Genetics
Initiating as Speculative Buy with a $0.70 (12-month) price target
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J